|
WU-MDACC Inter-Institutional Molecular Imaging Center
|
4P50CA094056-16
|
$1,286,033
|
$77,162
|
ACHILEFU, SAMUEL
|
WASHINGTON UNIVERSITY
|
|
Mapping cancer micro-environments for acute leukemia
|
1R01CA202025-01A1
|
$463,557
|
$231,779
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Initiation of DNA Replication in Mammalian Cells
|
ZIA BC 010411
|
$1,016,066
|
$152,410
|
Aladjem, Mirit
|
CCR (NCI)
|
|
Immuno/Immuno-Gene Therapies for Thoracic Malignancies
|
4P01CA066726-19
|
$1,182,811
|
$331,187
|
ALBELDA, STEVEN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Identifying vulnerabilities and therapeutic targets in Glioma Stem Cells
|
5K22CA197053-02
|
$200,880
|
$200,880
|
BADR, CHRISTIAN
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Role of the long non-coding RNA PVT1 in cancer
|
1R01CA200643-01A1
|
$347,700
|
$347,700
|
BAGCHI, ANINDYA
|
UNIVERSITY OF MINNESOTA
|
|
Dusp4 in breast cancer: tumor suppressor biology and therapeutic strategies
|
6R00CA181491-03
|
$250,586
|
$125,293
|
BALKO, JUSTIN
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Platform for MR-Guided Neurotherapeutic Drug Delivery
|
5R44CA177205-03
|
$512,806
|
$256,403
|
BARKER, EDWARD
|
INSERT, INC.
|
|
Histone Methyltransferases as a Target for Lung Cancer Prevention
|
5R01CA183296-03
|
$567,957
|
$283,979
|
BELINSKY, STEVEN
|
LOVELACE BIOMEDICAL & ENVIRONMENTAL RES
|
|
SPORE: Brain Tumore SPORE Grant
|
4P50CA097257-14
|
$2,006,093
|
$100,305
|
BERGER, MITCHEL
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Career Development in Pediatric and Medical Oncology
|
2K12CA076930-16A1
|
$531,466
|
$175,384
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Pediatric Oncology Research Training Program
|
4T32CA009351-38
|
$248,472
|
$49,694
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cellular biofactories for therapeutic protein synthesis in tumor microenvironment
|
5R21CA193064-03
|
$288,035
|
$288,035
|
BHATNAGAR, PARIJAT
|
SRI INTERNATIONAL
|
|
Vaccine Immunotoxin and Radioimmunotherapy of Primary and Metastatic CNS Tumors
|
4P01CA154291-05
|
$2,641,256
|
$554,664
|
BIGNER, DARELL
|
DUKE UNIVERSITY
|
|
Research Training Program in Surgical Oncology
|
4T32CA091078-15
|
$366,683
|
$36,668
|
BLAND, KIRBY
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Oncolytic Virotherapy in Hepatocellular Cancer
|
3DP2CA195764-01S1
|
$219,502
|
$109,751
|
BORAD, MITESH
|
MAYO CLINIC ARIZONA
|
|
A Genetic Toolbox for the Identification and Interrogation of Tumor Cells of Origin, Propagation, and Recurrence From Patient-derived Oncogenic Drivers
|
1R33CA202900-01
|
$418,128
|
$418,128
|
BREUNIG, JOSHUA
|
CEDARS-SINAI MEDICAL CENTER
|
|
Optimization of a clinical stage nanoparticle drug delivery platform
|
2R44CA186410-02A1
|
$1,000,000
|
$500,000
|
BROWN, BOB
|
DICERNA PHARMACEUTICALS, INC.
|
|
Combining STAT3-silencing and oncolytic vaccinia virus to enhance anti-tumor therapeutic activity
|
1F32CA199981-01A1
|
$56,118
|
$56,118
|
BYRD, DANIEL
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Cancer Prevention and Treatment by Activation of a Brain-Adipocyte Axis
|
4R01CA166590-04
|
$319,550
|
$159,775
|
CAO, LEI
|
OHIO STATE UNIVERSITY
|
|
Mechanisms of Chromosome Maintenance in Bacteria
|
ZIA BC 010277
|
$596,242
|
$59,624
|
Chattoraj, Dhruba
|
CCR (NCI)
|
|
Potential therapeutic implications of targeting miR-150 in acute myeloid leukemia
|
5R01CA182528-04
|
$336,114
|
$336,114
|
CHEN, JIANJUN
|
UNIVERSITY OF CINCINNATI
|
|
Direct coregulation of Notch1 by Zmiz1 in T-cell leukemia
|
5R01CA196604-02
|
$354,563
|
$177,282
|
CHIANG, MARK
|
UNIVERSITY OF MICHIGAN
|
|
MOTILITY AND INVASION
|
5P01CA100324-14
|
$2,028,990
|
$202,899
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Telomere Biology
|
ZIA BC 011519
|
$1,183,392
|
$23,668
|
Cooper, Julia
|
CCR (NCI)
|
|
Lambda Genetic Networks and Lambda Red-Mediated Recombination
|
ZIA BC 010336
|
$1,025,379
|
$256,345
|
Court, Donald
|
CCR (NCI)
|
|
Natural mutagenesis of human genomes by endogenous retrotransposons
|
4R01CA166661-05
|
$318,513
|
$105,109
|
DEVINE, SCOTT
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Molecular Basis of Cancer Virus Replication, Transformation, and Innate Defense
|
3P01CA016038-42S1
|
$106,835
|
$13,889
|
DIMAIO, DANIEL
|
YALE UNIVERSITY
|
|
Molecular Basis of Cancer Virus Replication, Transformation, and Innate Defense
|
5P01CA016038-42
|
$980,728
|
$127,495
|
DIMAIO, DANIEL
|
YALE UNIVERSITY
|
|
SPORE in Genitourinary Cancer
|
4P50CA091846-15
|
$1,910,080
|
$191,008
|
DINNEY, COLIN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Mechanisms of tumor escape from anti-angiogenic therapy
|
5R01CA177875-03
|
$312,777
|
$156,389
|
DUDLEY, ANDREW
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Clinical production of viral vectors for cancer gene therapy
|
ZIC BC 010989
|
$451,117
|
$451,117
|
Feldman, Steven
|
CCR (NCI)
|
|
Disrupting tumor/bone malignant interactions with multifunctional cytokine sonodelivery
|
1R01CA196947-01A1
|
$361,974
|
$361,974
|
FIGUEIREDO, MARXA
|
PURDUE UNIVERSITY
|
|
Identification of non-coding RNAs to therapeutically target undruggable pathways in metastatic lung adenocarcinoma and squamous cell carcinoma
|
1R35CA197452-01
|
$100,026
|
$100,026
|
FLORES, ELSA
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Identification of non-coding RNAs to therapeutically target undruggable pathways in metastatic lung adenocarcinoma and squamous cell carcinoma
|
7R35CA197452-02
|
$816,402
|
$816,402
|
FLORES, ELSA
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Targeting epigenetic regulators using bacterial macromolecule delivery
|
5R01CA188382-03
|
$309,166
|
$309,166
|
FORBES, NEIL
|
UNIVERSITY OF MASSACHUSETTS AMHERST
|
|
Combination Gene Therapy and Th1-Th2 Therapy
|
ZIA BC 011219
|
$252,285
|
$126,143
|
Fowler, Daniel
|
CCR (NCI)
|
|
Developing novel strategies for altering the cytokine microenvironment of tumors
|
5R21CA184433-02
|
$200,318
|
$200,318
|
FRELINGER, JOHN
|
UNIVERSITY OF ROCHESTER
|
|
Gene Therapy and Radiation Therapy for Prostate Cancer
|
4R01CA160289-05
|
$273,589
|
$136,795
|
FREYTAG, SVEND
|
Henry Ford Health System
|
|
Adoptive T cell Therapy for Pediatric Leukemia
|
ZIA BC 011565
|
$1,035,891
|
$310,767
|
Fry, Terry
|
CCR (NCI)
|
|
Reporter Gene Technologies for Integrated Cancer Diagnostics
|
5R01CA082214-16
|
$375,250
|
$93,813
|
GAMBHIR, SANJIV
|
STANFORD UNIVERSITY
|
|
Mechanisms in Polyomavirus Assembly
|
5R01CA037667-32
|
$371,424
|
$92,856
|
GARCEA, ROBERT
|
UNIVERSITY OF COLORADO
|
|
Enhancing Immunological Memory Using Aptamer targeted siRNA Delivery to T Cells
|
3R01CA181598-03S1
|
$100,813
|
$50,407
|
GILBOA, ELI
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Enhancing Immunological Memory Using Aptamertargeted siRNA Delivery to T Cells
|
5R01CA181598-03
|
$318,513
|
$159,257
|
GILBOA, ELI
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
|
ZIA BC 005598
|
$373,564
|
$74,713
|
Gottesman, Michael
|
CCR (NCI)
|
|
Nanoparticle modified Human Fat Derived Mesenchymal Stem Cells for Brain Cancer
|
1R01CA195503-01A1
|
$370,575
|
$370,575
|
GREEN, JORDAN
|
JOHNS HOPKINS UNIVERSITY
|
|
Targeting Translation Control in Malignant Glioma
|
4R01CA124756-10
|
$253,655
|
$253,655
|
GROMEIER, MATTHIAS
|
DUKE UNIVERSITY
|
|
Liver Cancer Risk with rAAV Gene Therapy
|
5R01CA190144-02
|
$636,568
|
$636,568
|
GROMPE, MARKUS
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Mechanism, Regulation and Application of miRNA pathway in cancer
|
ZIA BC 011566
|
$829,419
|
$248,826
|
Gu, Shuo
|
CCR (NCI)
|
|
Preclinical Validation of U1 Adaptors for Suppression of KRAS in Pancreatic Cancer
|
5R21CA191622-02
|
$155,875
|
$155,875
|
GUNDERSON, SAMUEL
|
RUTGERS, THE STATE UNIV OF N.J.
|
Total relevant funding to Gene Therapy for this search: $37,266,434
|